Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008 - PubMed (original) (raw)

Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008

Tiffany G Sheu et al. Antimicrob Agents Chemother. 2008 Sep.

Abstract

The surveillance of seasonal influenza virus susceptibility to neuraminidase (NA) inhibitors was conducted using an NA inhibition assay. The 50% inhibitory concentration values (IC(50)s) of 4,570 viruses collected globally from October 2004 to March 2008 were determined. Based on mean IC(50)s, A(H3N2) viruses (0.44 nM) were more sensitive to oseltamivir than A(H1N1) viruses (0.91 nM). The opposite trend was observed with zanamivir: 1.06 nM for A(H1N1) and 2.54 nM for A(H3N2). Influenza B viruses exhibited the least susceptibility to oseltamivir (3.42 nM) and to zanamivir (3.87 nM). To identify potentially resistant viruses (outliers), a threshold of a mean IC(50) value + 3 standard deviations was defined for type/subtype and drug. Sequence analysis of outliers was performed to identify NA changes that might be associated with reduced susceptibility. Molecular markers of oseltamivir resistance were found in six A(H1N1) viruses (H274Y) and one A(H3N2) virus (E119V) collected between 2004 and 2007. Some outliers contained previously reported mutations (e.g., I222T in the B viruses), while other mutations [e.g., R371K and H274Y in B viruses and H274N in A(H3N2) viruses) were novel. The R371K B virus outlier exhibited high levels of resistance to both inhibitors (>100 nM). A substantial variance at residue D151 was observed among A(H3N2) zanamivir-resistant outliers. The clinical relevance of newly identified NA mutations is unknown. A rise in the incidence of oseltamivir resistance in A(H1N1) viruses carrying the H274Y mutation was detected in the United States and in other countries in the ongoing 2007 to 2008 season. As of March 2008, the frequency of resistance among A(H1N1) viruses in the United States was 8.6% (50/579 isolates). The recent increase in oseltamivir resistance among A(H1N1) viruses isolated from untreated patients raises public health concerns and necessitates close monitoring of resistance to NA inhibitors.

PubMed Disclaimer

Figures

FIG. 1.

FIG. 1.

Assessment of the IC50s for oseltamivir, using the chemiluminescent NAI assay. (A) Oseltamivir-sensitive A/Massachusetts/6/2006 (H1N1) virus; (B) oseltamivir-resistant A/Massachusetts/5/2007 (H1N1) virus with the mutation H274Y; (C) oseltamivir-sensitive A/Washington/1/2007 (H3N2) virus; (D) oseltamivir-resistant A/Texas/12/2007(H3N2) virus with the E119V mutation. x axis, NA activity in relative light units (RLUs). y axis, oseltamivir concentrations (nM) on a logarithmic scale. Data points indicate actual activity measured at a single time point using a plate reader, Victor 3V. The data line represents the best-fit curve generated using Robosage software.

Similar articles

Cited by

References

    1. Baum, E. Z., P. C. Wagaman, L. Ly, I. Turchi, J. Le, D. Bucher, and K. Bush. 2003. A point mutation in influenza B neuraminidase confers resistance to peramivir and loss of slow binding. Antivir. Res. 59:13-22. - PubMed
    1. Baz, M., Y. Abed, J. McDonald, and G. Boivin. 2006. Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child. Clin. Infect. Dis. 43:1555-1561. - PubMed
    1. Bright, R. A., M. J. Medina, X. Xu, G. Perez-Oronoz, T. R. Wallis, X. M. Davis, L. Povinelli, L. Cox, and A. I. Klimov. 2005. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 366:1175-1181. - PubMed
    1. Bright, R. A., D. Shay, J. Bresee, A. Klimov, N. Cox, and J. Ortiz. 2006. High levels of adamantane resistance among influenza A(H3N2) viruses and interim guidelines for use of antiviral agents: United States, 2005-06 influenza season. MMWR Morb. Mortal. Wkly. Rep. 55:44-46. - PubMed
    1. Bright, R. A., D. K. Shay, B. Shu, N. J. Cox, and A. I. Klimov. 2006. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 295:891-894. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources